Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Mads Lamm Larsen"'
Autor:
Christian Ammitzbøll, Marianne Kragh Thomsen, Lars Erik Bartels, Cecilie Bo Hansen, Marie‐Louise From Hermansen, Mathias Hänel, Rasmus Klose‐Jensen, Mads Lamm Larsen, Morgan Oliver Lauritsen, Clara Elbæk Mistegaard, Susan Mikkelsen, Janne Bille Mønster Olesen, Esben Uggerby Næser, Morten Aagaard Nielsen, Christian Erikstrup, Peter Garred, Ellen‐Margrethe Hauge, Anne Troldborg
Publikováno v:
ACR Open Rheumatology, Vol 6, Iss 8, Pp 519-528 (2024)
Objective Rituximab (RTX)‐treated patients exhibit suboptimal responses to COVID‐19 vaccines. However, existing research primarily involves patients already receiving RTX when vaccines were introduced, failing to account for the current landscape
Externí odkaz:
https://doaj.org/article/9bde49ba5c9543f19c3a4b260d0f6a21
Autor:
Mads Lamm Larsen, Oliver Heidmann Pedersen, Anne-Mette Hvas, Peter Buur van Kooten Niekerk, Søren Bønløkke, Steen Dalby Kristensen, Erik Lerkevang Grove
Publikováno v:
Platelets, Vol 30, Iss 3, Pp 322-328 (2019)
Insufficient platelet inhibition has been reported in up to 40% of aspirin-treated patients, including patients with essential thrombocytosis. To maintain sufficient platelet inhibition, a shorter dosing interval with aspirin has been suggested. We a
Externí odkaz:
https://doaj.org/article/b3da491241fd443f99f4c33d13fc8cbb
Autor:
Peter H. Nissen, Jenny Q D Tran, Erik Lerkevang Grove, Oliver Heidmann Pedersen, Anne-Mette Hvas, Mads Lamm Larsen, Steen Dalby Kristensen
Publikováno v:
Tran, J Q D, Pedersen, O H, Larsen, M L, Grove, E L, Kristensen, S D, Hvas, A-M & Nissen, P H 2020, ' Platelet microRNA expression and association with platelet maturity and function in patients with essential thrombocythemia ', Platelets, vol. 31, no. 3, pp. 365-372 . https://doi.org/10.1080/09537104.2019.1636019
Essential thrombocythemia (ET) is characterized by persistently elevated platelet counts and an increased risk of thromboembolic events. Dysregulated expression of small noncoding microRNAs (miRNAs) have been shown in ET and may influence platelet ma
Publikováno v:
Larsen, M L, Grove, E L, Kristensen, S D & Hvas, A-M 2020, ' Benefits and Harm of Treatment with P2Y12 Inhibitors beyond 12 Months in Patients with Coronary Artery Disease ', Seminars in Thrombosis and Hemostasis, vol. 46, no. 4, pp. 446-456 . https://doi.org/10.1055/s-0039-3399567
The trade-off between the benefits and harm of long-term (> 12 months) treatment with P2Y12 inhibitors in patients with coronary artery disease (CAD) after percutaneous coronary intervention (PCI) remains controversial. This review was conducted in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e7b1a68d6808e4d81315c0a65713e1f
https://pure.au.dk/portal/da/publications/benefits-and-harm-of-treatment-with-p2y12-inhibitors-beyond-12-months-in-patients-with-coronary-artery-disease(96e31977-2383-45ff-8bdd-2f6cfd0bc5b4).html
https://pure.au.dk/portal/da/publications/benefits-and-harm-of-treatment-with-p2y12-inhibitors-beyond-12-months-in-patients-with-coronary-artery-disease(96e31977-2383-45ff-8bdd-2f6cfd0bc5b4).html
Autor:
Mads Lamm Larsen, Steen Dalby Kristensen, Anne-Mette Hvas, Erik Lerkevang Grove, Søren Bønløkke, Peter Buur van Kooten Niekerk, Oliver Heidmann Pedersen
Publikováno v:
Larsen, M L, Pedersen, O H, Hvas, A-M, Niekerk, P B V K, Bønløkke, S, Kristensen, S D & Grove, E L 2019, ' Once-versus twice-daily aspirin treatment in patients with essential thrombocytosis ', Platelets, vol. 30, no. 3, pp. 322-328 . https://doi.org/10.1080/09537104.2018.1430356
Insufficient platelet inhibition has been reported in up to 40% of aspirin-treated patients, including patients with essential thrombocytosis. To maintain sufficient platelet inhibition, a shorter dosing interval with aspirin has been suggested. We a
Autor:
Anne-Mette Hvas, Peter Buur van Kooten Niekerk, Peter H. Nissen, Mads Lamm Larsen, Oliver Heidmann Pedersen, Steen Dalby Kristensen, Erik Lerkevang Grove, Søren Bønløkke
Publikováno v:
Pedersen, O H, Larsen, M L, Grove, E L, van Kooten Niekerk, P B, Bønløkke, S, Nissen, P H, Kristensen, S D & Hvas, A-M 2018, ' Platelet Characteristics in Patients with Essential Thrombocytosis ', Cytometry. Part B: Clinical Cytometry, vol. 94, no. 6, pp. 918-927 . https://doi.org/10.1002/cyto.b.21642
BACKGROUND: Essential thrombocytosis (ET) is a myeloproliferative disorder characterized by an increased platelet count. ET is associated with an increased risk of thrombosis, and procoagulant features of the disease may include an increased number o
Autor:
Erik Lerkevang Grove, Anne-Mette Hvas, Mads Lamm Larsen, Steen Dalby Kristensen, Oliver Heidmann Pedersen
Publikováno v:
Pedersen, O H, Larsen, M L, Kristensen, S D, Hvas, A-M & Grove, E L 2017, ' Recurrent Cardiovascular Events Despite Antiplatelet Therapy in a Patient with Polycythemia Vera and Accelerated Platelet Turnover ', American Journal of Case Reports, vol. 18, pp. 945-948 . https://doi.org/10.12659/AJCR.904148
The American Journal of Case Reports
The American Journal of Case Reports
Patient: Male, 58 Final Diagnosis: STEMI Symptoms: Angina pectoris Medication:— Clinical Procedure: — Specialty: Hematology Objective: Unusual clinical course Background: Clopidogrel is commonly used in the prevention and treatment of cardiovascu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e757cddb93c86e5454b11e65961de96c
https://pure.au.dk/portal/da/publications/recurrent-cardiovascular-events-despite-antiplatelet-therapy-in-a-patient-with-polycythemia-vera-and-accelerated-platelet-turnover(89d7edf5-1b9a-4565-94e5-e0a8d44bb1f0).html
https://pure.au.dk/portal/da/publications/recurrent-cardiovascular-events-despite-antiplatelet-therapy-in-a-patient-with-polycythemia-vera-and-accelerated-platelet-turnover(89d7edf5-1b9a-4565-94e5-e0a8d44bb1f0).html